- Section 1 - About the Company
- Oxurion NV - Key Facts
- Oxurion NV - Key Employees
- Oxurion NV - Key Employee Biographies
- Oxurion NV - Major Products and Services
- Oxurion NV - History
- Oxurion NV - Company Statement
- Oxurion NV - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Section 2 – Company Analysis
- Company Overview
- Oxurion NV - Business Description
- Other Break-up: Income from Royalties
- Performance
- Other Break-up: Sales
- Performance
- Oxurion NV - Corporate Strategy
- Oxurion NV - SWOT Analysis
- SWOT Analysis - Overview
- Oxurion NV - Strengths
- Oxurion NV - Weaknesses
- Oxurion NV - Opportunities
- Oxurion NV - Threats
- Oxurion NV - Key Competitors
- Section 3 – Company Financial Ratios
- Financial Ratios - Capital Market Ratios
- Financial Ratios - Annual Ratios
- Performance Chart
- Financial Performance
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Section 4 – Company’s Lifesciences Financial Deals and Alliances
- Oxurion NV, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
- Oxurion NV, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
- Oxurion NV, Recent Deals Summary
- Section 5 – Company’s Recent Developments
- Apr 10, 2024: Oxurion Receives EUR 450,000 in the Framework of the Atlas Funding Program : Eleventh Tranche Fully Issued and Paid-up
- Mar 05, 2024: Oxurion Receives EUR 300,000 in the Framework of the Atlas Funding Program Tenth Tranche Fully Issued and Paid-Up
- Sep 29, 2023: Oxurion Publishes First Half 2023 Results
- May 15, 2023: Oxurion Announces Results of the Annual Shareholders’ Meeting of 2 May 2023
- Mar 31, 2023: Oxurion Publishes 2022 Annual Report
- Mar 14, 2023: Oxurion Provides Update on Recruitment for KALAHARI Phase 2, Part B Trial of Novel PKal Inhibitor THR-149 in Diabetic Macular Edema and Announces Board Changes
- Section 6 – Appendix
- Methodology
- Ratio Definitions
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Oxurion NV, Key Facts
- Oxurion NV, Key Employees
- Oxurion NV, Key Employee Biographies
- Oxurion NV, Major Products and Services
- Oxurion NV, History
- Oxurion NV, Subsidiaries
- Oxurion NV, Key Competitors
- Oxurion NV, Ratios based on current share price
- Oxurion NV, Annual Ratios
- Oxurion NV, Annual Ratios (Cont...1)
- Oxurion NV, Annual Ratios (Cont...2)
- Oxurion NV, Interim Ratios
- Oxurion NV, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
- Oxurion NV, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
- Oxurion NV, Recent Deals Summary
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
- List of Figures
- Oxurion NV, Performance Chart (2019 - 2023)
- Oxurion NV, Ratio Charts
- Oxurion NV, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
- Oxurion NV, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook